Dr. Faries is a surgical oncologist and the co-director of the Melanoma Program and head of Surgical Oncology at The Angeles Clinic and Research Institute in Los Angeles. He also is the surgical director for Experimental Therapeutics at Cedars-Sinai Medical Center. He received his undergraduate education at Haverford College and completed medical school at Cornell. He completed his residency in general surgery at the University of Pennsylvania and a surgical oncology fellowship at the John Wayne Cancer Institute.

Dr. Faries is principal investigator (PI) for the second Multicenter Selective Lymphadenectomy Trial, an international trial including more than 4,000 subjects. He serves on the American Joint Committee on Cancer (AJCC) Melanoma Staging Committee and the American Society of Clinical Oncology (ASCO)/Society of Surgical Oncology (SSO) Melanoma Guidelines panel and is a member of the editorial board of the Annals of Surgical Oncology. His research focuses on surgical treatment of melanoma and immunotherapy.

Dr. Jeffrey Gregg is senior director of Clinical Pathology and Molecular Diagnostics and professor of Pathology at the University of California Davis School of Medicine and UC Davis Health. He is director of the UC Davis Comprehensive Cancer Center Genomics Shared Resource where he uses next generation sequencing and genomic technologies for analysis of tumors and biomarker discovery. He is a member of the UC Davis Molecular Tumor Board and participates in other Molecular Tumor Boards throughout the United States. His clinical and research focus is on developing liquid biopsy as a high-value clinical tool for cancer screening, diagnosis, and surveillance.

Regina Jacob, MD, MSCE, is an assistant professor of Clinical Medicine at The Lewis Katz School of Medicine at Temple University in North Philadelphia.  She received her MD degree from The George Washington University in Washington, D.C., completed her internal medicine residency at Temple University Hospital, and earned a master’s degree in Clinical Epidemiology at The Weill Cornell Medical College of Cornell University in Manhattan, New York.

Dr. Jacob has two main research interests which both assess psychological adjustment and co-morbid medical conditions.  She conducted a study called Coping with Lymphoma to Enhance Adjustment and Reduce Stress, which assessed the psychological adjustments which may occur after a diagnosis of lymphoma.  She continues to grow her cancer survivorship expertise in education, designing curricula to educate internal medicine residents on how to appropriately tailor primary care for patients with a history of cancer. 

Her second research interest involves assessing co-morbid conditions that result from chronic and cumulative trauma exposure.  She is currently conducting a study called Trauma Alert! How Social Complexity Contributes to Medical Complexity, which assesses the prevalence of post-traumatic stress disorder (PTSD), adverse childhood experiences, depression, and co-morbidity in an underserved primary care population. While the effects of poverty on healthcare are known, there is still a large amount of work to be done with regards to how trauma associated with poverty results in negative health behaviors and subsequent poor medical and psychological outcomes.